Altered expression of Aβ metabolism-associated molecules from d-galactose/AlCl3 induced mouse brain

Mechanisms of Ageing and Development

Volumn 130, Issue 4, 2009, Pages 248-252

  Luo, Yun ^a   Niu, Fengnan ^b   Sun, Zongzheng ^a   Cao, Wangsen ^c   Zhang, Xin ^a   Guan, Dening ^a   Lv, Zhimai ^a   zhang, Bing ^a   Xu, Yun ^a,b,d  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NANJING UNIVERSITY   (China)

Author keywords

Aluminum trichloride; Alzheimer's disease; Amyloid protein; d galactose

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALUMINUM CHLORIDE; AMYLOID BETA PROTEIN; BETA SECRETASE; GALACTOSE; INSULINASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; ALUMINUM DERIVATIVE; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; CHLORIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; SECRETASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; SPATIAL MEMORY; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MEMORY; METABOLISM;

MUS; RATTUS;

ALUMINUM COMPOUNDS; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BEHAVIOR, ANIMAL; BRAIN; CHLORIDES; GALACTOSE; GENE EXPRESSION REGULATION; MEMORY; MICE; NEPRILYSIN; RECEPTORS, LDL;

EID: 60849096351     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2008.12.005     Document Type: Article

References (33)

1. Banks W.A., Niehoff M.L., Drago D., et al. Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier. Brain Res. 1116 1 (2006) 215-221
2. Cui X., Zuo P., Zhang Q., et al. Chronic systemic d-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J. Neurosci. Res. 84 3 (2006) 647-654
3. Deane R., Wu Z., Sagare A., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43 3 (2004) 333-344
4. Fukumoto H., Rosene D.L., Moss M.B., et al. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am. J. Pathol. 164 2 (2004) 719-725
5. Ghidoni R., Benussi L., Glionna M., et al. Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment. J. Neural Transm. 115 7 (2008) 1047-1050
6. Goedert M., and Spillantini M.G. A century of Alzheimer's disease. Science 314 5800 (2006) 777-781
7. Hebert S.S., Horre K., Nicolai L., et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S. A. 105 17 (2008) 6415-6420
8. Hua X., Lei M., Ding J., et al. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: a potential contribution to Alzheimer's disease processes. Exp. Neurol. 210 2 (2008) 709-718
9. Kao S.C., Krichevsky A.M., Kosik K.S., et al. BACE1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem. 279 3 (2004) 1942-1949
10. Kawahara M., Kato M., and Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res. Bull. 55 2 (2001) 211-217
11. Lewczuk P., and Wiltfang J. Neurochemical dementia diagnostics: State of the art and research perspectives. Proteomics 8 6 (2008) 1292-1301
12. Li G.L., Farooque M., Holtz A., et al. Changes of beta-amyloid precursor protein after compression trauma to the spinal cord: an experimental study in the rat using immunohistochemistry. J. Neurotrauma 12 3 (1995) 269-277
13. Lu J., Zheng Y.L., Luo L., et al. Quercetin reverses d-galactose induced neurotoxicity in mouse brain. Behav. Brain Res. 171 2 (2006) 251-260
14. Luques L., Shoham S., and Weinstock M. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil. Exp. Neurol. 206 2 (2007) 209-219
15. Marr R.A., Rockenstein E., Mukherjee A., et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23 6 (2003) 1992-1996
16. Matsuda H. The role of neuroimaging in mild cognitive impairment. Neuropathology 27 6 (2007) 570-577
17. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 7000 (2004) 631-639
18. McKee A.C., Au R., Cabral H.J., et al. Visual association pathology in preclinical Alzheimer disease. J. Neuropathol. Exp. Neurol. 65 6 (2006) 621-630
19. Miller M.C., Tavares R., Johanson C.E., et al. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 1230 (2008) 273-280
20. Naggara O., Oppenheim C., Rieu D., et al. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res. 146 3 (2006) 243-249
21. Reilly C.E. Neprilysin content is reduced in Alzheimer brain areas. J. Neurol. 248 2 (2001) 159-160
22. Sasaki N., Toki S., Chowei H., et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 888 2 (2001) 256-262
23. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 2 (2001) 741-766
24. Shen Y.X., Xu S.Y., Wei W., et al. Melatonin reduces memory changes and neural oxidative damage in mice treated with d-galactose. J. Pineal Res. 32 3 (2002) 173-178
25. Song X., Bao M., Li D., et al. Advanced glycation in d-galactose induced mouse aging model. Mech. Ageing Dev. 108 3 (1999) 239-251
26. Tanzi R.E., Moir R.D., and Wagner S.L. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43 5 (2004) 605-608
27. Tian J., Ishibashi K., Ishibashi K., et al. Advanced glycation end product-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc. Natl. Acad. Sci. U. S. A. 102 33 (2005) 11846-11851
28. Wei H., Li L., Song Q., et al. Behavioural study of the d-galactose induced aging model in C57BL/6J mice. Behav. Brain Res. 157 2 (2005) 245-251
29. Xu Y., Zhang W., Klaus J., et al. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 103 39 (2006) 14489-14494
30. Yasojima K., Akiyama H., McGeer E.G., et al. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci. Lett. 297 2 (2001) 97-100
31. Yoon S.Y., Choi J.E., Yoon J.H., et al. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol. Dis. 22 2 (2006) 435-444
32. Zhang L., Xing Y., Ye C.F., et al. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav. Brain Res. 173 2 (2006) 246-254
33. Zhou Y.T., Zhang Z.X., Chan P., et al. Genetic association between low-density lipoprotein receptor-related protein gene polymorphisms and Alzheimer's disease in Chinese Han population. Neurosci. Lett. 444 1 (2008) 109-111